Cognitive impairment as a determinant of response to management plans after heart failure admission

2021 ◽  
Author(s):  
Quan L. Huynh ◽  
Kristyn Whitmore ◽  
Kazuaki Negishi ◽  
Carmine G. DePasquale ◽  
James L. Hare ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cognitive Impairment ◽  
Management Plans ◽  
Heart Failure Admission

Cognitive impairment in myocardial infarction and heart failure

2021 ◽  
Author(s):  
Kewarin Jinawong ◽  
Nattayaporn Apaijai ◽  
Nipon Chattipakorn ◽  
Siriporn C. Chattipakorn
Keyword(s):  
Myocardial Infarction ◽  
Heart Failure ◽  
Cognitive Impairment

scholarly journals RELATIONSHIP BETWEEN DIASTOLIC FUNCTION AND HEART FAILURE ADMISSION IN PATIENTS WITH MODERATE AORTIC STENOSIS

2021 ◽  
Vol 77 (18) ◽  
pp. 1703
Author(s):  
Mika Maeda ◽  
Shunsuke Kagawa ◽  
Taku Omori ◽  
Goki Uno ◽  
Shunsuke Shimada ◽  
...  
Keyword(s):  
Heart Failure ◽  
Aortic Stenosis ◽  
Diastolic Function ◽  
Heart Failure Admission

Characteristics of the Premortal Heart Failure Admission

2008 ◽  
Vol 14 (6) ◽  
pp. S98
Author(s):  
Gerald L. Cooke ◽  
Marc A. Silver
Keyword(s):  
Heart Failure ◽  
Heart Failure Admission

Impact of diabetes on cognitive impairment and disability in elderly hospitalized patients with heart failure

2013 ◽  
Vol 13 (4) ◽  
pp. 1035-1042 ◽  
Author(s):  
Giorgio Basile ◽  
Andrea Crucitti ◽  
Maria D Cucinotta ◽  
Paolo Figliomeni ◽  
Antonio Lacquaniti ◽  
...  
Keyword(s):  
Heart Failure ◽  
Cognitive Impairment ◽  
Hospitalized Patients ◽  
Patients With Heart Failure ◽  
Elderly Hospitalized Patients

Abstract 17667: Local Atrophy of Parahippocampal Gyrus is Prominent in Heart Failure Patients Without Dementia

Circulation ◽  
2014 ◽  
Vol 130 (suppl_2) ◽  
Author(s):  
Tomomi Meguro
Keyword(s):  
Heart Failure ◽  
Cognitive Impairment ◽  
Potential Risk ◽  
Brain Atrophy ◽  
Three Dimensional ◽  
Left Ventricular ◽  
Parahippocampal Gyrus ◽  
Control Group ◽  
Z Score ◽  
Heart Failure Patients

Introduction: The exacerbation of heart failure (HF) induces brain damage and the cognitive impairment that attenuates the effects of treatment. The medial lateral lobe of brain, including parahippocampal gyrus, is known to reduce its volume in patients with cognitive disorder especially in Alzheimer’s disease. The magnetic resonance imaging (MRI) scans identify morphological changes in the brains of patients with HF. Therefore, the Voxel-based morphometry (VBM) of three-dimensional brain MRI may contribute to predict the potential risk of mild cognitive impairment (MCI) of patients with HF. Hypothesis: The severity of local atrophy of parahippocampal gyrus, a potential risk of MCI, is prominent in heart failure patients without dementia. Methods: Ten HF patients (age 72+/-15 years, NYHA class II, EF43+/-15 %) and 9 control (age 76+/- 8 years) were enrolled. Patients with dementia were excluded from this study. Three dimensional T1 weighted sagittal images of whole brain were taken using 1.5T MRI. Image analysis was performed to evaluate the severity of local brain atrophy of gray matter using 2mm VBM by the software based on statistical parametric mapping. The Z-score value of volume of interest (VOI) was calculated to evaluate the severity of atrophy in parahippocampal gyrus. Results: The severity of total brain atrophy was similar between HF (8.3+/-3.4%) and control (8.0+/-4.1%). However, as shown in the figure of representative cases, the Z-score value of VOI (pink circle), reflecting the severity of atrophy in parahippocampal gyrus (white arrows), was larger in HF patients group (1.4+/-0.7) in comparison with control group (0.8+/-0.4, P=0.034). The Z-score value was not correlated with age, ejection fraction, left atrial dimension, left ventricular dimensions, or BNP in HF group. Conclusions: In patients with HF, atrophy in parahippocampal gyrus was prominent in comparison with control. Patients with heart failure have potential risk of MCI and dementia.

scholarly journals Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?

2017 ◽  
Vol 20 (2) ◽  
pp. 317-322 ◽  
Author(s):  
Gad Cotter ◽  
Marco Metra ◽  
Beth A. Davison ◽  
Guillaume Jondeau ◽  
John G.F. Cleland ◽  
...  
Keyword(s):  
Heart Failure ◽  
Blood Pressure ◽  
Systolic Blood Pressure ◽  
Acute Heart Failure ◽  
Blood Pressure Reduction ◽  
Pressure Reduction ◽  
Heart Failure Admission

scholarly journals Chronic heart failure as multimorbid state

2019 ◽  
Vol 26 (4) ◽  
pp. 90-101 ◽  
Author(s):  
L. G. Voronkov ◽  
A.V. Liashenko ◽  
N. A. Tkach ◽  
L. P. Paraschenyuk
Keyword(s):  
Diabetes Mellitus ◽  
Heart Failure ◽  
Cognitive Impairment ◽  
Chronic Heart Failure ◽  
Iron Deficiency ◽  
Arterial Hypertension ◽  
Renal Dysfunction ◽  
Life Quality ◽  
High Class ◽  
High Level

Regulatory, structural and functional disturbances of other organs and systems (kidney, hepar, vessels, skeletal muscles, brain etc) play the substantial role in CHF. These disturbances may be the conseguences of pre-existing states (hypertension, diabetes, hypo- or hyperthyreoidism etc) and from, other side, may reflect the progressive inherent changes in chronic heart failure (CHF) per se. In particular, currently relevant comorbidities in this syndrome are insulin resistance, diabetes mellitus, renal dysfunction, cognitive impairment, depression peripheral myopathy. Every of them demonstrate the close pathophysiologic interplay with CHF which results in clinical prognosis impairment and in decrease of life quality. Prevalence of renal dysfunction described in 39 % of patients with CHF in our research. Renal dysfunction connected with older age, high class of NYHA, diabetes mellitus, arterial hypertension, higher level of citrulline and uric acid in patients with CHF. Patients with iron deficiency characterized with high class of NYHA, low functionality and poor quality of life. In patients with iron deficiency noted high level of mortality and many critical clinical events. Prevalence of cognitive impairment described in 85 % of patients with CHF in our research. Cognitive dysfunction associated with older age, high class of NYHA, diabetes mellitus, arterial hypertension, bad life quality, high level of ceruloplasmin in patients with CHF. Taking to account above-mentioned comorbidities in quideline-recommended management of CHF and the use of additional therapeutic approaches targeted to its treatment represent the contemporary strategy of personalized treatment in this syndrome.

Sign in / Sign up

Export Citation Format

Share Document